-
1
-
-
34247585475
-
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
-
DOI 10.1128/JVI.02696-06
-
Abbink, P., et al. (2007). Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81, 4654-4663. (Pubitemid 46668663)
-
(2007)
Journal of Virology
, vol.81
, Issue.9
, pp. 4654-4663
-
-
Abbink, P.1
Lemckert, A.A.C.2
Ewald, B.A.3
Lynch, D.M.4
Denholtz, M.5
Smits, S.6
Holterman, L.7
Damen, I.8
Vogels, R.9
Thorner, A.R.10
O'Brien, K.L.11
Carville, A.12
Mansfield, K.G.13
Goudsmit, J.14
Havenga, M.J.E.15
Barouch, D.H.16
-
2
-
-
33745062611
-
Production and formulation of adenovirus vectors
-
DOI 10.1007/10-008, Gene Therapy and Gene Delivery Systems
-
Altaras, N., et al. (2005). Production and formulation of adenovirus vectors. In Advances in Biochemical Engineering/Biotechnology. DV Schaffer and W Zhou, eds. (Springer-Verlag, Berlin) pp. 193-260. (Pubitemid 44617182)
-
(2005)
Advances in Biochemical Engineering/Biotechnology
, vol.99
, pp. 193-260
-
-
Altaras, N.E.1
Aunins, J.G.2
Evans, R.K.3
Kamen, A.4
Konz, J.O.5
Wolf, J.J.6
-
3
-
-
84871769381
-
First-in-human evaluation of the safety and immunogenicity of a recombinabf adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
-
Baden, L., et al. (2013). First-in-human evaluation of the safety and immunogenicity of a recombinabf adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J. Infect. Dis. 207, 240-247.
-
(2013)
J. Infect. Dis.
, vol.207
, pp. 240-247
-
-
Baden, L.1
-
4
-
-
0034047177
-
An improved anion-exchange HPLC method for the detection and purification of adenoviral particles
-
Blanche, F., et al. (2000). An improved anion-exchange HPLC method for the detection and purification of adenoviral particles.. Gene Ther. 7, 1055-1062. (Pubitemid 30398355)
-
(2000)
Gene Therapy
, vol.7
, Issue.12
, pp. 1055-1062
-
-
Blanche, F.1
Cameron, B.2
Barbot, A.3
Ferrero, L.4
Guillemin, T.5
Guyot, S.6
Somarriba, S.7
Bisch, D.8
-
5
-
-
0029838375
-
A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4
-
Brough, D., et al. (1996). A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J. Virol. 70, 6497-6501. (Pubitemid 26266881)
-
(1996)
Journal of Virology
, vol.70
, Issue.9
, pp. 6497-6501
-
-
Brough, D.E.1
Lizonova, A.2
Hsu, C.3
Kulesa, V.A.4
Kovesdi, I.5
-
6
-
-
27544495302
-
Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: Methods and implications
-
DOI 10.1038/sj.gt.3302611, PII 3302611
-
Burova, E., and Ioffe, E. (2005). Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications. Gene Ther. 12, S5-S17. (Pubitemid 41541749)
-
(2005)
Gene Therapy
, vol.12
, Issue.SUPPL. 1
-
-
Burova, E.1
Ioffe, E.2
-
8
-
-
72949097270
-
Purification of adenovirus vectors by combined anion exchange and gel filtration chromatography
-
Eglon, M., Duffy, A., O'Brien, T., and Strappe, P. (2009). Purification of adenovirus vectors by combined anion exchange and gel filtration chromatography. J. Gene Med. 11, 978-989.
-
(2009)
J. Gene Med.
, vol.11
, pp. 978-989
-
-
Eglon, M.1
Duffy, A.2
O'Brien, T.3
Strappe, P.4
-
11
-
-
17344373287
-
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses
-
Fallaux, F., et al. (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9, 1909-1917. (Pubitemid 28439096)
-
(1998)
Human Gene Therapy
, vol.9
, Issue.13
, pp. 1909-1917
-
-
Fallaux, F.J.1
Bout, A.2
Van Der Velde, I.3
Van Den Wollenberg, D.J.M.4
Hehir, K.M.5
Keegan, J.6
Auger, C.7
Cramer, S.J.8
Van Ormondt, H.9
Van Der Eb, A.J.10
Valerio, D.11
Hoeben, R.C.12
-
12
-
-
33745344073
-
Development of Novel E1-Complementary Cells for Adenoviral Production Free of Replication-Competent Adenovirus
-
DOI 10.1016/j.ymthe.2006.02.020, PII S1525001606001183
-
Farson, D., et al. (2006). Development of novel E1-complementary cells for adenoviral production free of replication-competent adenovirus. Mol. Ther. 14, 305-311. (Pubitemid 43942350)
-
(2006)
Molecular Therapy
, vol.14
, Issue.2
, pp. 305-311
-
-
Farson, D.1
Tao, L.2
Ko, D.3
Li, Q.4
Brignetti, D.5
Segawa, K.6
Mittelstaedt, D.7
Harding, T.8
Yu, D.-C.9
Li, Y.10
-
13
-
-
84899067055
-
-
FDA Gene Therapy Letter Available at (Accessed February 28, 2014)
-
FDA Gene Therapy Letter. 2000). Gene Therapy Letter: Preclinical and Clinical Issues. Available at http://www.fda.gov/ohrms/dockets/ac/01/briefing/ 3739b1-05.pdf (Accessed February 28, 2014).
-
(2000)
Gene Therapy Letter: Preclinical and Clinical Issues
-
-
-
14
-
-
0035133766
-
Serum-free recombinant production of adenovirus using a hollow fiber capillary system
-
Gardner, T., et al. (2001). Serum-free recombinant production of adenovirus using a hollow fiber capillary system. Bio-Techniques 30, 422-427. (Pubitemid 32158569)
-
(2001)
BioTechniques
, vol.30
, Issue.2
, pp. 422-427
-
-
Gardner, T.A.1
Ko, S.-C.2
Yang, L.3
Cadwell, J.J.S.4
Chung, L.W.K.5
Kao, C.6
-
15
-
-
0037081381
-
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes
-
DOI 10.1016/S0264-410X(01)00450-9, PII S0264410X01004509
-
Gilbert, S., et al. (2002). Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine 20, 1039-1045. (Pubitemid 34135938)
-
(2002)
Vaccine
, vol.20
, Issue.7-8
, pp. 1039-1045
-
-
Gilbert, S.C.1
Schneider, J.2
Hannan, C.M.3
Hu, J.T.4
Plebanski, M.5
Sinden, R.6
Hill, A.V.S.7
-
16
-
-
0041395649
-
Role of early region 3 (E3) in pathogenesis of adenovirus disease
-
DOI 10.1073/pnas.86.10.3823
-
Ginsberg, H., et al. (1989). Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86, 3823-3827. (Pubitemid 19141837)
-
(1989)
Proceedings of the National Academy of Sciences of the United States of America
, vol.86
, Issue.10
, pp. 3823-3827
-
-
Ginsberg, H.S.1
Lundholm-Beauchamp, U.2
Horswood, R.L.3
Pernis, B.4
Wold, W.S.M.5
Chanock, R.M.6
Prince, G.A.7
-
17
-
-
84899061922
-
-
Europe, Patent No. EP1506287 A2
-
Goerke, A., Konz, J., Lee, A., and To, C. (2005a). Methods of adenovirus purification. Europe, Patent No. EP1506287 A2.
-
(2005)
Methods of Adenovirus Purification
-
-
Goerke, A.1
Konz, J.2
Lee, A.3
To, C.4
-
18
-
-
21344468852
-
Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA
-
DOI 10.1002/bit.20406
-
Goerke, A., et al. (2005b). Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA. Biotechnol. Bioeng., 91, 12-21. (Pubitemid 40910748)
-
(2005)
Biotechnology and Bioengineering
, vol.91
, Issue.1
, pp. 12-21
-
-
Goerke, A.R.1
To, B.C.S.2
Lee, A.L.3
Sagar, S.L.4
Konz, J.O.5
-
19
-
-
0017710978
-
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
-
Graham, F., Smiley, J., Russell, W., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
-
(1977)
J. Gen. Virol.
, vol.36
, pp. 59-74
-
-
Graham, F.1
Smiley, J.2
Russell, W.3
Nairn, R.4
-
20
-
-
0036431515
-
A new scalable method for the purification of recombinant adenovirus vectors
-
DOI 10.1089/10430340260355338
-
Green, A., et al. (2002). A new scalable method for the purification of recombinant adenovirus vectors. Hum. Gene Ther. 13, 1921-1934. (Pubitemid 35341034)
-
(2002)
Human Gene Therapy
, vol.13
, Issue.16
, pp. 1921-1934
-
-
Green, A.P.1
Huang, J.J.2
Scott, M.O.3
Kierstead, T.D.4
Beaupre, I.5
Gao, G.-P.6
Wilson, J.M.7
-
21
-
-
33746803686
-
Novel replication-incompetent adenoviral B-group vectors: High vector stability and yield in PER.C6 cells
-
DOI 10.1099/vir.0.81956-0
-
Havenga, M., et al. (2006). Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells. J. Gen. Virol. 87, 2135-2143. (Pubitemid 44178090)
-
(2006)
Journal of General Virology
, vol.87
, Issue.8
, pp. 2135-2143
-
-
Havenga, M.1
Vogels, R.2
Zuijdgeest, D.3
Radosevic, K.4
Mueller, S.5
Sieuwerts, M.6
Weichold, F.7
Damen, I.8
Kaspers, J.9
Lemckert, A.10
Van Meerendonk, M.11
Van Der Vlugt, R.12
Holterman, L.13
Hone, D.14
Skeiky, Y.15
Mintardjo, R.16
Gillissen, G.17
Barouch, D.18
Sadoff, J.19
Goudsmit, J.20
more..
-
22
-
-
10344254303
-
Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence
-
Hehir, K., et al. (1996). Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J. Virol. 70, 8459-8467. (Pubitemid 26378423)
-
(1996)
Journal of Virology
, vol.70
, Issue.12
, pp. 8459-8467
-
-
Hehir, K.M.1
Armentano, D.2
Cardoza, L.M.3
Choquette, T.L.4
Berthelette, P.B.5
White, G.A.6
Couture, L.A.7
Everton, M.B.8
Keegan, J.9
Martin, J.M.10
Pratt, D.A.11
Smith, M.P.12
Smith, A.E.13
Wadsworth, S.C.14
-
24
-
-
0028825639
-
Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography
-
Huyghe, B., et al. (1995). Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum. Gene Ther. 6, 1403-1416.
-
(1995)
Hum. Gene Ther.
, vol.6
, pp. 1403-1416
-
-
Huyghe, B.1
-
25
-
-
18144363442
-
Advanced methods of adenovirus vector production for human gene therapy: Roller bottles, microcarriers, and hollow fibers
-
September/October
-
Isayeva, T., Kotova, O., Kranshykh, V., and Kotov, A. (2003). Advanced methods of adenovirus vector production for human gene therapy: roller bottles, microcarriers, and hollow fibers. Bioprocess. J. September/October, 75-81.
-
(2003)
Bioprocess. J.
, pp. 75-81
-
-
Isayeva, T.1
Kotova, O.2
Kranshykh, V.3
Kotov, A.4
-
26
-
-
68549097881
-
Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan
-
Ishiko, H., and Aoki, K. (2009). Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan. J. Clin. Microbiol. 47, 2678-2679.
-
(2009)
J. Clin. Microbiol.
, vol.47
, pp. 2678-2679
-
-
Ishiko, H.1
Aoki, K.2
-
27
-
-
3042704538
-
Development and optimization of an adenovirus production process
-
DOI 10.1002/jgm.503
-
Kamen, A., and Henry, O. (2004). Development and optimization of an adenovirus production process. J. Gene Med. 6, S184-S192. (Pubitemid 40228027)
-
(2004)
Journal of Gene Medicine
, vol.6
, Issue.SUPPL. 1
-
-
Kamen, A.1
Henry, O.2
-
28
-
-
0035810734
-
Improved high-performance liquid chromatographic method in the analysis of adenovirus particles
-
DOI 10.1016/S0378-4347(00)00597-1, PII S0378434700005971
-
Klyushnicheno, V., Bernier, A., Kamen, A., and Harmsen, E. (2001). Improved high-performance liquid chromatographic method in the analysis of adenovirus particles. J. Chromatogr. B 755, 27-36. (Pubitemid 32324066)
-
(2001)
Journal of Chromatography B: Biomedical Sciences and Applications
, vol.755
, Issue.1-2
, pp. 27-36
-
-
Klyushnichenko, V.1
Bernier, A.2
Kamen, A.3
Harmsen, E.4
-
29
-
-
41949119694
-
WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007
-
Knezevic, I., et al. (2008). WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007. Biologicals 36, 203-211.
-
(2008)
Biologicals
, vol.36
, pp. 203-211
-
-
Knezevic, I.1
-
30
-
-
16344374932
-
Development of a purification process for adenovirus: Controlling virus aggregation to improve the clearance of host cell DNA
-
DOI 10.1021/bp049644r
-
Konz, J., Lee, A., Lewis, J., and Sagar, S. (2005). Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA. Biotechnol. Prog. 21, 466-472. (Pubitemid 40466419)
-
(2005)
Biotechnology Progress
, vol.21
, Issue.2
, pp. 466-472
-
-
Konz, J.O.1
Lee, A.L.2
Lewis, J.A.3
Sagar, S.L.4
-
31
-
-
33846013953
-
High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype
-
DOI 10.1038/sj.gt.3302851, PII 3302851
-
Kuhn, I., et al. (2007). High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotype. Gene Ther. 14, 180-184. (Pubitemid 46043823)
-
(2007)
Gene Therapy
, vol.14
, Issue.2
, pp. 180-184
-
-
Kuhn, I.1
Larsen, B.2
Gross, C.3
Hermiston, T.4
-
32
-
-
57749179936
-
Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography
-
Lee, D., Kim, B.M., and Seol, D. (2009). Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography. Biochem. Biophys. Res. Commun. 378, 640-644.
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.378
, pp. 640-644
-
-
Lee, D.1
Kim, B.M.2
Seol, D.3
-
33
-
-
0028658416
-
Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells
-
Lochmuller, H., et al. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
-
(1994)
Hum. Gene Ther.
, vol.5
, pp. 1485-1491
-
-
Lochmuller, H.1
-
34
-
-
29744470594
-
Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy
-
DOI 10.1128/JVI.79.24.15265-15276.2005
-
Madisch, I., et al. (2005). Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy. J. Virol. 79, 15265-15276. (Pubitemid 43032309)
-
(2005)
Journal of Virology
, vol.79
, Issue.24
, pp. 15265-15276
-
-
Madisch, I.1
Harste, G.2
Pommer, H.3
Heim, A.4
-
35
-
-
33846894083
-
A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells
-
DOI 10.1016/j.vaccine.2006.12.011, PII S0264410X06013314
-
Marzio, G., et al. (2007). A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells. Vaccine 25, 2228-2237. (Pubitemid 46227700)
-
(2007)
Vaccine
, vol.25
, Issue.12
, pp. 2228-2237
-
-
Marzio, G.1
Kerkvliet, E.2
Bogaards, J.A.3
Koelewijn, S.4
De Groot, A.5
Gijsbers, L.6
Weverling, G.J.7
Vogels, R.8
Havenga, M.9
Custers, J.10
Pau, M.G.11
Guichoux, J.Y.12
Lewis, J.13
Goudsmit, J.14
-
36
-
-
83555170908
-
Performance characteristics of host-cell DNA quantification methods
-
Mehta, S., and Keer, J.T. (2007). Performance characteristics of host-cell DNA quantification methods. BioProcess International 5, 44-58.
-
(2007)
Bio Process International
, vol.5
, pp. 44-58
-
-
Mehta, S.1
Keer, J.T.2
-
38
-
-
2642549761
-
Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches
-
DOI 10.1128/JVI.78.12.6200-6208.2004
-
Murakami, P., et al. (2004). Common structure of rare replicationdeficient E1-positive particles in adenoviral vector batches. J. Virol. 78, 6200-6208. (Pubitemid 38715918)
-
(2004)
Journal of Virology
, vol.78
, Issue.12
, pp. 6200-6208
-
-
Murakami, P.1
Havenga, M.2
Fawaz, F.3
Vogels, R.4
Marzio, G.5
Pungor, E.6
Files, J.7
Do, L.8
Goudsmit, J.9
McCaman, M.10
-
39
-
-
77952953556
-
Massively parallel sequencing, a new method for detecting adventitious agents
-
Onions, D., and Kolman, J. (2010). Massively parallel sequencing, a new method for detecting adventitious agents. Biologicals 38, 377-380.
-
(2010)
Biologicals
, vol.38
, pp. 377-380
-
-
Onions, D.1
Kolman, J.2
-
41
-
-
84934439444
-
Canine adenovirus downstream processing protocol
-
M. Chillon and A. Bosch, eds. (Springer, New York)
-
Puig, M., Piedra, J., Miravet, S., and Segura, M. (2014). Canine adenovirus downstream processing protocol. In Adenovirus: Methods and Protocols. M. Chillon and A. Bosch, eds. (Springer, New York) pp. 197-210.
-
(2014)
In Adenovirus: Methods and Protocols.
, pp. 197-210
-
-
Puig, M.1
Piedra, J.2
Miravet, S.3
Segura, M.4
-
42
-
-
0031065201
-
+ T Cell-Mediated Protective Immunity Against Malaria
-
Rodrigues, E., et al. (1997). Single immunizing dose of recombinant adenovirus efficiently induces CD8 + T cellmediated protective immunity against malaria. J. Immunol. 158, 1268-1274. (Pubitemid 127469951)
-
(1997)
Journal of Immunology
, vol.158
, Issue.3
, pp. 1268-1274
-
-
Rodrigues, E.G.1
Zavala, F.2
Eichinger, D.3
Wilson, J.M.4
Tsuji, M.5
-
43
-
-
84899081709
-
-
Available at Accessed February 25, 2014
-
Rolli, G. (2012). Progress toward a low COGs PER.C6 based IPV. Available at www.who.int/immunization-standards/vaccine-quality/rolli-crucell-progress- ipv-oct12.pdf (Accessed February 25, 2014)
-
(2012)
Progress Toward A Low COGs PER.C6 Based IPV
-
-
Rolli, G.1
-
44
-
-
84899051507
-
-
Available at Accessed February 26, 2014
-
Sachs, J., Kremer, M., and Hamoudi, A. (1999). The case for a vaccine purchase fund. Available at www.earth.columbia.edu/sitefiles/file/ Sachs%20Writing/1999/CIDMimeo-1999-CaseforaVaccinePurchaseFund-June1999.pdf (Accessed February 26, 2014)
-
(1999)
The Case for A Vaccine Purchase Fund
-
-
Sachs, J.1
Kremer, M.2
Hamoudi, A.3
-
45
-
-
80052308543
-
Overview of current scalable methods for purification of viral vectors
-
O. Merten and M. Al-Rubeai, eds. (Springer Science and Business Media, New York)
-
Segura, M., Kamen, A., and Garnier, A. (2011). Overview of current scalable methods for purification of viral vectors. In Viral Vectors for Gene Therapy: Methods and Protocols. O. Merten and M. Al-Rubeai, eds. (Springer Science and Business Media, New York) pp. 89-116.
-
(2011)
In Viral Vectors for Gene Therapy: Methods and Protocols
, pp. 89-116
-
-
Segura, M.1
Kamen, A.2
Garnier, A.3
-
46
-
-
16944365650
-
Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles
-
Shabram, P., et al. (1997). Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum. Gene Ther. 8, 453-465. (Pubitemid 27140548)
-
(1997)
Human Gene Therapy
, vol.8
, Issue.4
, pp. 453-465
-
-
Shabram, P.W.1
Giroux, D.D.2
Goudreau, A.M.3
Gregory, R.J.4
Horn, M.T.5
Huyghe, B.G.6
Liu, X.7
Nunnally, M.H.8
Sugarman, B.J.9
Sutjipto, S.10
-
47
-
-
0035949826
-
Validation of a high-performance liquid chromatographic assay for the quantification of adenovirus type 5 particles
-
DOI 10.1016/S0378-4347(01)00330-9, PII S0378434701003309
-
Transfiguracion, J., et al. (2001). Validation of a high-performance liquid chromatographic assay for the quantification of adenovirus type 5 particles. J. Chromatogr. B. Biomed. Sci. Appl. 761, 187-194. (Pubitemid 32817108)
-
(2001)
Journal of Chromatography B: Biomedical Sciences and Applications
, vol.761
, Issue.2
, pp. 187-194
-
-
Transfiguracion, J.1
Bernier, A.2
Arcand, N.3
Chahal, P.4
Kamen, A.5
-
49
-
-
36249019262
-
High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector
-
DOI 10.1099/vir.0.83119-0
-
Vogels, R., et al. (2007). High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector. J. Gen. Virol. 88, 2915-2924. (Pubitemid 350131228)
-
(2007)
Journal of General Virology
, vol.88
, Issue.11
, pp. 2915-2924
-
-
Vogels, R.1
Zuijdgeest, D.2
Van Meerendonk, M.3
Companjen, A.4
Gillissen, G.5
Sijtsma, J.6
Melis, I.7
Holterman, L.8
Radosevic, K.9
Goudsmit, J.10
Havenga, M.J.E.11
-
50
-
-
80053528637
-
Computational analysis of two species C human adenoviruses provides evidence of a novel virus
-
Walsh, M.P., et al. (2011). Computational analysis of two species C human adenoviruses provides evidence of a novel virus. J. Clin. Microbiol. 49, 3482-3490.
-
(2011)
J. Clin. Microbiol.
, vol.49
, pp. 3482-3490
-
-
Walsh, M.P.1
-
51
-
-
22044436145
-
Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: Toward a universal method for the facile quantitation of virus and vector potency
-
DOI 10.1016/j.vaccine.2005.04.023, PII S0264410X05004627
-
Wang, F., et al. (2005). Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency. Vaccine 23, 4500-4508. (Pubitemid 40967978)
-
(2005)
Vaccine
, vol.23
, Issue.36
, pp. 4500-4508
-
-
Wang, F.1
Puddy, A.C.2
Mathis, B.C.3
Montalvo, A.G.4
Louis, A.A.5
McMackin, J.L.6
Xu, J.7
Zhang, Y.8
Tan, C.Y.9
Schofield, T.L.10
Wolf, J.J.11
Lewis, J.A.12
-
52
-
-
33746267429
-
A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative polymerase chain reaction
-
DOI 10.1089/hum.2006.17.728
-
Wang, L., et al. (2006). A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative polymerase chain reaction. Hum. Gene Ther. 17, 728-740. (Pubitemid 44100718)
-
(2006)
Human Gene Therapy
, vol.17
, Issue.7
, pp. 728-740
-
-
Wang, L.1
Wang, C.J.2
Tan, C.Y.3
Hsu, D.4
Hennessey Jr., J.P.5
-
54
-
-
84899128407
-
-
WHO Available at (Accessed February 28, 2014)
-
WHO. 2007). Meeting Report, WHO study group on cell substrates for Production of Biologicals. Available at http://www.who.int/biologicals/ publications/meetings/areas/vaccines/cells/Cells.FINAL.MtgRep.IK.26-Sep-07.pdf? ua = 1 (Accessed February 28, 2014).
-
(2007)
Meeting Report, WHO Study Group on Cell Substrates for Production of Biologicals
-
-
-
55
-
-
84899062636
-
-
Available at Accessed February 26, 2014
-
Wilson, P. (2010). Available at http://www.oxfam.org/en/policy/giving- developing-countries-best-shot-vaccine-access (Accessed February 26, 2014)
-
(2010)
-
-
Wilson, P.1
-
56
-
-
27544460155
-
-
USA, Patent No. US6194191 B1
-
Zhang, S., Thwin, C., Wu, Z., and Cho, T. (2001). Method for the production and purification of adenoviral vectors. USA, Patent No. US6194191 B1.
-
(2001)
Method for the Production and Purification of Adenoviral Vectors
-
-
Zhang, S.1
Thwin, C.2
Wu, Z.3
Cho, T.4
|